Literature DB >> 22057282

Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats.

Pengmin Chen1, Jingbo Zhao, Hans Gregersen.   

Abstract

BACKGROUND AND AIMS: Gastrointestinal disorders and symptoms are common in diabetic patients. Advanced glycation end-products (AGEs) and their receptor (RAGE) have been proposed as an important pathological mechanism underlying diabetic complications, such as diabetic cardiopathy, retinopathy, nephropathy, etc. The aims were to study the distribution of AGE and RAGE in the normal and diabetic small intestine and colon in rats and the possible relationship between AGEs/RAGE and diabetes-induced intestinal structural remodeling.
METHODS: Diabetic and age-matched normal rats survived for 56 days. The body weight and blood glucose were measured regularly until day 56. Jejunal, ileal, and colonic segments were excised. The wet weight per unit length and the layer thickness were measured. AGE and RAGE were detected by immunohistochemical staining.
RESULTS: The wet weight per unit length in the three segments and the layer thickness in jejunum and ileum increased in the diabetic rats. The staining density of AGE in diabetic rats was higher in the villi of jejunum and ileum, and in the crypt and circumferential muscle layer of ileum compared to normal rats. The staining intensity of RAGE increased in ganglia, crypt, and brush border of diabetic jejunum and ileum as well as in ganglia of diabetic colon. Positive association was found between the accumulation of AGE and RAGE and the thickness of the different layers.
CONCLUSIONS: The expression of AGE and RAGE is up-regulated in the small intestine and colon of diabetic rats. The increased AGE and RAGE levels may contribute to diabetic GI dysfunction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057282     DOI: 10.1007/s10620-011-1951-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

Review 1.  Clinical review: The role of advanced glycation end products in progression and complications of diabetes.

Authors:  Su-Yen Goh; Mark E Cooper
Journal:  J Clin Endocrinol Metab       Date:  2008-01-08       Impact factor: 5.958

2.  The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells.

Authors:  J T Handa; K M Reiser; H Matsunaga; L M Hjelmeland
Journal:  Exp Eye Res       Date:  1998-04       Impact factor: 3.467

Review 3.  Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

Authors:  A M Schmidt; O Hori; J Brett; S D Yan; J L Wautier; D Stern
Journal:  Arterioscler Thromb       Date:  1994-10

4.  Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.

Authors:  J R Rumble; M E Cooper; T Soulis; A Cox; L Wu; S Youssef; M Jasik; G Jerums; R E Gilbert
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 5.  Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus.

Authors:  Jingbo Zhao; Jens Brøndum Frøkjaer; Asbjørn Mohr Drewes; Niels Ejskjaer
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

6.  Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.

Authors:  Cory Toth; Ling Ling Rong; Christina Yang; Jose Martinez; Fei Song; Noor Ramji; Valentine Brussee; Wei Liu; Jeff Durand; Minh Dang Nguyen; Ann Marie Schmidt; Douglas W Zochodne
Journal:  Diabetes       Date:  2007-11-26       Impact factor: 9.461

7.  The intestinal brush border membrane in diabetes. Studies of sucrase-isomaltase metabolism in rats with streptozotocin diabetes.

Authors:  W A Olsen; H Korsmo
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 8.  Diabetes and the enteric nervous system.

Authors:  B Chandrasekharan; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2007-10-17       Impact factor: 3.598

Review 9.  Diabetes mellitus, part 1: physiology and complications.

Authors:  Muralitharan Nair
Journal:  Br J Nurs       Date:  2007 Feb 8-21

Review 10.  AGE, RAGE, and ROS in diabetic nephropathy.

Authors:  Adeline L Y Tan; Josephine M Forbes; Mark E Cooper
Journal:  Semin Nephrol       Date:  2007-03       Impact factor: 5.299

View more
  21 in total

1.  The gut as a sensory organ.

Authors:  John B Furness; Leni R Rivera; Hyun-Jung Cho; David M Bravo; Brid Callaghan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

2.  Research on the traditional Chinese medicine treating gastrointestinal motility in diabetic rats by improving biomechanical remodeling and neuroendocrine regulation.

Authors:  Jiaxing Tian; Min Li; Jingbo Zhao; Junling Li; Guifang Liu; Zhong Zhen; Yang Cao; Hans Gregersen; Xiaolin Tong
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  Advanced glycation end-product expression is upregulated in the gastrointestinal tract of type 2 diabetic rats.

Authors:  Peng-Min Chen; Hans Gregersen; Jing-Bo Zhao
Journal:  World J Diabetes       Date:  2015-05-15

4.  Gastrointestinal complications of diabetes mellitus.

Authors:  Babu Krishnan; Shithu Babu; Jessica Walker; Adrian B Walker; Joseph M Pappachan
Journal:  World J Diabetes       Date:  2013-06-15

5.  Effect of tangweian jianji on upper gastrointestinal remodeling in streptozotocin-induced diabetic rats.

Authors:  Gui-Fang Liu; Jing-Bo Zhao; Zhong Zhen; Hong Sha; Peng-Min Chen; Min Li; Jia-Cheng Zhang; Ming-Ze Yuan; Wen Gao; Hans Gregersen; Xiao-Lin Tong
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

6.  Remodeling of the rat distal colon in diabetes: function and ultrastructure.

Authors:  Marion J Siegman; Masumi Eto; Thomas M Butler
Journal:  Am J Physiol Cell Physiol       Date:  2015-11-11       Impact factor: 4.249

7.  Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats.

Authors:  Annabel Biruete; Shruthi Srinivasan; Kalisha D O'Neill; Colby J Vorland; Kathleen M Hill Gallant; Weijing Cai; Jaime Uribarri; Nancy Johnston; Matthew R Allen; Neal X Chen; Sharon M Moe
Journal:  Am J Nephrol       Date:  2020-03-06       Impact factor: 3.754

8.  RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.

Authors:  Mathias Dahlmann; Anna Okhrimenko; Patrick Marcinkowski; Marc Osterland; Pia Herrmann; Janice Smith; Claus W Heizmann; Peter M Schlag; Ulrike Stein
Journal:  Oncotarget       Date:  2014-05-30

9.  The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.

Authors:  So Yeon Kong; Masayoshi Takeuchi; Hideyuki Hyogo; Gail McKeown-Eyssen; Sho-Ichi Yamagishi; Kazuaki Chayama; Peter J O'Brien; Pietro Ferrari; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Nadia Bastide; Franck Carbonnel; Tilman Kühn; Rudolf Kaaks; Heiner Boeing; Krasimira Aleksandrova; Antonia Trichopoulou; Pagona Lagiou; Effie Vasilopoulou; Giovanna Masala; Valeria Pala; Maria Santucci De Magistris; Rosario Tumino; Alessio Naccarati; H B Bueno-de-Mesquita; Petra H Peeters; Elisabete Weiderpass; J Ramón Quirós; Paula Jakszyn; María-José Sánchez; Miren Dorronsoro; Diana Gavrila; Eva Ardanaz; Martin Rutegård; Hanna Nyström; Nicholas J Wareham; Kay-Tee Khaw; Kathryn E Bradbury; Isabelle Romieu; Heinz Freisling; Faidra Stavropoulou; Marc J Gunter; Amanda J Cross; Elio Riboli; Mazda Jenab; W Robert Bruce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-24       Impact factor: 4.254

10.  Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20-30 years.

Authors:  L R DeChristopher; J Uribarri; K L Tucker
Journal:  Nutr Diabetes       Date:  2016-03-07       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.